Literature DB >> 35371527

Categorizing continuous biomarkers: More cons than pros.

Yalan Zhang1, Annette M Molinaro1.   

Abstract

Entities:  

Year:  2022        PMID： 35371527      PMCID： PMC8965051          DOI： 10.1093/nop/npac012

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN： 2054-2577


× No keyword cloud information.
  6 in total

Review 1.  Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Authors:  Jyothi Subramanian; Richard Simon
Journal:  J Natl Cancer Inst       Date:  2010-03-16       Impact factor: 13.506

Review 2.  Statistical considerations on prognostic models for glioma.

Authors:  Annette M Molinaro; Margaret R Wrensch; Robert B Jenkins; Jeanette E Eckel-Passow
Journal:  Neuro Oncol       Date:  2015-12-08       Impact factor: 12.300

3.  Prediction error estimation: a comparison of resampling methods.

Authors:  Annette M Molinaro; Richard Simon; Ruth M Pfeiffer
Journal:  Bioinformatics       Date:  2005-05-19       Impact factor: 6.937

Review 4.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

5.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

Review 6.  Statistical Considerations in the Evaluation of Continuous Biomarkers.

Authors:  Mei-Yin C Polley; James J Dignam
Journal:  J Nucl Med       Date:  2021-02-12       Impact factor: 10.057
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.